Skip to main content
Signal8

GREY MICHAEL G

SEC insider (Form 3/4/5 filer). CIK 0001240122. Director at OnKure Therapeutics, Inc. (OKUR) and 2 other issuers. 29 reported Form 4/5 transactions since Sep 2024; latest on Aug 7, 2026. Located in BOULDER, CO.

Companies GREY MICHAEL G has filed insider reports for

  • OnKure Therapeutics, Inc. (OKUR): Director
  • Mirum Pharmaceuticals, Inc. (MIRM): Director
  • SPRUCE BIOSCIENCES, INC. (SPRB): Director, Officer, Executive Chairman
GREY MICHAEL G profile photo

GREY MICHAEL G

CIK: 0001240122

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)3 (10.3%)

Position reduction

Option Exercises (M)3 (10.3%)

Derivative conversions

Awards (A)16 (55.2%)

Compensation grants

Other (G, F, J, C, D, …)7 (24.1%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (3)

OnKure Therapeutics, Inc. logo
OKUR

OnKure Therapeutics, Inc.

Director
Mirum Pharmaceuticals, Inc. logo
MIRM

Mirum Pharmaceuticals, Inc.

Director
SPRUCE BIOSCIENCES, INC. logo
SPRB

SPRUCE BIOSCIENCES, INC.

DirectorOfficer

Discretionary Trading P&L

Holdings

Transaction History (29 total)

  • OnKure Therapeutics, Inc. logo
    OKUR

    OnKure Therapeutics, Inc.

    Aug 7, 2026
    Award

    Stock Option (right to buy)

    Direct
    22.4K shares-
  • Mirum Pharmaceuticals, Inc. logo
    MIRM

    Mirum Pharmaceuticals, Inc.

    Jun 15, 2026
    Award

    Restricted Stock Units

    Direct
    2K shares-
  • Mirum Pharmaceuticals, Inc. logo
    MIRM

    Mirum Pharmaceuticals, Inc.

    Jun 15, 2026
    Award

    Stock Option (right to buy)

    Direct
    3.8K shares-
  • OnKure Therapeutics, Inc. logo
    OKUR

    OnKure Therapeutics, Inc.

    Jun 4, 2026
    Award

    Stock Option (right to buy)

    Direct
    7.7K shares-
  • SPRUCE BIOSCIENCES, INC. logo
    SPRB

    SPRUCE BIOSCIENCES, INC.

    May 21, 2026
    Award

    Stock Option (Right to Buy)

    Direct
    1.7K shares-
  • Mirum Pharmaceuticals, Inc. logo
    MIRM

    Mirum Pharmaceuticals, Inc.

    Dec 19, 2025
    Exercise
    Direct
    50K shares at avg. $2.94$147K
  • Mirum Pharmaceuticals, Inc. logo
    MIRM

    Mirum Pharmaceuticals, Inc.

    Dec 19, 2025
    Sale
    Direct
    50K shares at avg. $78.00$3.9M
  • SPRUCE BIOSCIENCES, INC. logo
    SPRB

    SPRUCE BIOSCIENCES, INC.

    Dec 11, 2025
    Disposition

    Stock Option (Right to Buy)

    Direct
    1.3K shares-
  • SPRUCE BIOSCIENCES, INC. logo
    SPRB

    SPRUCE BIOSCIENCES, INC.

    Dec 11, 2025
    Award

    Stock Option (Right to Buy)

    Direct
    1.5K shares-
  • SPRUCE BIOSCIENCES, INC. logo
    SPRB

    SPRUCE BIOSCIENCES, INC.

    Dec 11, 2025
    Award

    Stock Option (Right to Buy)

    Direct
    1.3K shares-

1-10 of 29